NextVivo - Crunchbase Company Profile & Funding

Q: Where is NextVivo's headquarters?

NextVivo is located in Palo Alto, California, United States.

Q: Who invested in NextVivo?

NextVivo has 4 investors including Wilson Sonsini Goodrich & Rosati And Alexandria Venture Investments.

Q: When was the last funding round for NextVivo?

NextVivo closed its last funding round on obfuscated from a Seed round.

Q: How much funding has NextVivo raised to date?

NextVivo has raised obfuscated.

Overview

NextVivo

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About NextVivo

CB Rank

55167

NextVivo is a biotech company developing an immune organoid technology platform.

Founded

obfuscation

Private

Seed

Palo Alto, California, United States

1-10

www.nextvivo.bio

Biotechnology

Funding Rounds

Seed

OBF

obfuscation

Key People

Mark Davis: Co-Founder

Details

Legal Name

NextVivo Inc.

Operating Status

Active

Company Type

For Profit

Founders

Adam Margolin, Mark Davis

About the Company

NextVivo is a biotech company developing an immune organoid technology platform to transform the future of drug development. Its mission is to accelerate the development of safer, more effective therapies that are generated and tested in immune-competent human-derived models.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Immune Organoid Technology Platform

A 3D human tissue model retaining key immune cells and their interactions for drug development and testing.

Antibody Therapy Development

A platform to generate fully human therapeutic antibodies using lymphoid organoids that replicate adaptive immune responses.

Research & Development

NextVivo is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed
obfuscated obfuscation	Seed Round - NextVivo	4	obfuscated obfuscation	Khosla Ventures	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Wilson Sonsini Goodrich & Rosati	—	Seed Round - NextVivo	—
Wilson Sonsini Goodrich & Rosati	—	Seed Round - NextVivo	—
Wilson Sonsini Goodrich & Rosati	—	Seed Round - NextVivo	—
Wilson Sonsini Goodrich & Rosati	—	Seed Round - NextVivo	—
Wilson Sonsini Goodrich & Rosati	—	Seed Round - NextVivo	—